This Science News Wire page contains a press release issued by an organization
and is provided to you "as is" with little or no review from Science X staff.
DNA methylation and ischemic stroke
May 27th, 2020
Stroke is not only one of the three leading causes of death in humans, but also a common cause of chronic disability in adults. The pathogenesis of the stroke is quite variable. However, the genetic factors play an important role in the pathogenesis of ischemic stroke. Furthermore, epigenetic modifications provide a new direction to study the pathogenesis of ischemic stroke.
Recently, the group of researchers from Zhejiang University School of Medicine, performed a case-control study to determine the correlation between the DNA methylation in S-adenosylhomocysteine hydrolase (AHCY) and the risk of ischemic stroke.
In their paper, published in the journal BJBMS, they confirmed that the DNA methylation levels of AHCY were significantly associated with the risk of ischemic stroke. Hence, AHCY methylation could be used as a potential marker for the diagnosis of ischemic stroke. However, further evaluations with a larger sample size need to elucidate the relationship between AHCY gene methylation levels and ischemic stroke in multiple ethnic populations.
More information: Zhao L, Chen X, Zhou S, Lin Z, Yu X, Huang Y. DNA methylation of AHCY may increase the risk of ischemic stroke. Bosn J of Basic Med Sci. 2020
Provided by Association of Basic Medical Sciences of FBIH
DNA methylation and ischemic stroke (2020, May 27)
retrieved 15 July 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.